Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras
Delayed administration of donor lymphocyte infusion (DLI) to established mixed chimeras has been shown to achieve anti-tumor responses without graft-vs.-host disease (GVHD). Herein we show that de novo donor BM-derived T cells that are tolerant of the recipients are important in preventing GVHD in m...
Main Authors: | Wang, Hui, Yang, Yanping, Wang, Guanjun, Wang, Shumei, Yeap, Beow Yong, Sykes, Megan, Yang, Yong-Guang |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471915/ |
Similar Items
-
Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
by: Szyska, Martin, et al.
Published: (2016) -
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
by: He, Fiona, et al.
Published: (2016) -
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
by: Morin-Zorman, Sarah, et al.
Published: (2016) -
Chronic ocular GVHD: limbal and conjunctival stem cell allografts from the same hematopoietic stem cell donor
by: Elias F Jarade, et al.
Published: (2018-09-01) -
Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor
by: Bobadilla-Morales, Lucina, et al.
Published: (2015)